Sunny Pharmtech Inc. (TPEX:6676)

Sunny Pharmtech Revenue

In the year 2025, Sunny Pharmtech had annual revenue of 253.01M TWD, down -39.47%. Sunny Pharmtech had revenue of 105.73M in the half year ending June 30, 2025, a decrease of -40.39%.

• Revenue: 253.01M
• Revenue Growth: -39.47%
• P/S Ratio: 8.73
• Revenue / Employee: 1.60M
• Employees: 158
• Market Cap: 2.21B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	253.01M	-165.00M	-39.47%
Dec 31, 2024	418.01M	-10.82M	-2.52%
Dec 31, 2023	428.83M	69.24M	19.26%
Dec 31, 2022	359.59M	118.59M	49.21%
Dec 31, 2021	241.00M	-178.94M	-42.61%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

May 10, 2026

Data Sources Report a data error